300676.SZ · 华大基因
China A-shares · RS rating 92 · As of 2026-10-14
| Price | 42.34 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 96 / 91 / 48 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 25 / 32 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +21.2% |
| Distance from 52-week high | +28.5% |
| Market cap (USD) | $2.8B |